- 米国企業
- Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc.SHPH
| 2022年 12月31日 |
---|
Net loss | -3,028,448 |
---|
Depreciation | 5,972 |
---|
Change in fair value of warrant liability | -94,025 |
---|
Amortization of right-of-use asset | 60,860 |
---|
Amortization of debt discount | 885,505 |
---|
Gain on settlement of accounts payable | 328,687 |
---|
Gain on forgiveness of Paycheck Protection Program note payable | 73,007 |
---|
Gain on interest relief on conversion of notes payable | -12,625 |
---|
Stock-based compensation | 403,956 |
---|
Prepaid expenses | 156,282 |
---|
Accounts payable and accrued expenses | -382,881 |
---|
Accrued expenses – related parties | 12,500 |
---|
Accrued interest payable | -13,177 |
---|
Accrued interest payable - related parties | 51,188 |
---|
Operating lease liability | -66,553 |
---|
Net Cash used in Operating Activities | -2,710,454 |
---|
Proceeds from issuance of common shares | 10 |
---|
Repayment of note payable-related party | -50,000 |
---|
Proceeds from notes payable-related parties | 50,000 |
---|
Proceeds from notes payable | 600,715 |
---|
Net Cash provided by Financing Activities | 11 |
---|
Net change in cash | 8 |
---|
Interest | 39,201 |
---|
Shares issued for conversion of accrued interest | 16,340 |
---|
Common stock issued for conversion of convertible debt | 588,524 |
---|
Common stock issued for exercise of warrants with settlement of notes payable | 576,476 |
---|
Common stock issued for dividend payable | 402,068 |
---|